Nascent Biotech Inc.Nascent Biotech Inc.Nascent Biotech Inc.

Nascent Biotech Inc.

No trades
See on Supercharts

NBIO fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Nascent Biotech, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of monoclonal antibodies for the treatment of various forms of cancer. It focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Its products include Pritumumab, CLNH5, and MultiPharm. The company was founded by Mark C. Glassy on March 3, 2014 and is headquartered in North Palm Beach, FL.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
NBIO has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company